BRIEF-Biogen says new data reaffirm clinically meaningful benefit of Spinraza in individuals with spinal muscular atrophy across disease severity
June 29, 2017 at 07:54 AM EDT
* Biogen - new data reaffirm clinically meaningful benefit of Spinraza (nusinersen) in individuals with spinal muscular atrophy across disease severity
